Related Experiment Video
Updated: Oct 17, 2025

Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
Published on: January 26, 2019
Pattern Recognition Proteins: First Line of Defense Against Coronaviruses
Carlos A Labarrere1, Ghassan S Kassab1
1California Medical Innovations Institute, San Diego, CA, United States.
Abstract:
The rapid outbreak of COVID-19 caused by the novel coronavirus SARS-CoV-2 in Wuhan, China, has become a worldwide pandemic affecting almost 204 million people and causing more than 4.3 million deaths as of August 11 2021. This pandemic has placed a substantial burden on the global healthcare system and the global economy. Availability of novel prophylactic and therapeutic approaches are crucially needed to prevent development of severe disease leading to major complications both acutely and chronically. The success in fighting this virus results from three main achievements: (a) Direct killing of the SARS-CoV-2 virus; (b) Development of a specific vaccine, and (c) Enhancement of the host's immune system. A fundamental necessity to win the battle against the virus involves a better understanding of the host's innate and adaptive immune response to the virus. Although the role of the adaptive immune response is directly involved in the generation of a vaccine, the role of innate immunity on RNA viruses in general, and coronaviruses in particular, is mostly unknown. In this review, we will consider the structure of RNA viruses, mainly coronaviruses, and their capacity to affect the lungs and the cardiovascular system. We will also consider the effects of the pattern recognition protein (PRP) trident composed by (a) Surfactant proteins A and D, mannose-binding lectin (MBL) and complement component 1q (C1q), (b) C-reactive protein, and (c) Innate and adaptive IgM antibodies, upon clearance of viral particles and apoptotic cells in lungs and atherosclerotic lesions. We emphasize on the role of pattern recognition protein immune therapies as a combination treatment to prevent development of severe respiratory syndrome and to reduce pulmonary and cardiovascular complications in patients with SARS-CoV-2 and summarize the need of a combined therapeutic approach that takes into account all aspects of immunity against SARS-CoV-2 virus and COVID-19 disease to allow mankind to beat this pandemic killer.
Insights
This review explores the innate immune response to SARS-CoV-2, focusing on pattern recognition protein (PRP) trident therapies. Understanding innate immunity is crucial for developing effective treatments against COVID-19 complications.
Area of Science:
- Virology and Immunology
- Infectious Diseases
- Cardiovascular and Pulmonary Medicine
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant global health and economic burdens.
- Effective prophylactic and therapeutic strategies are urgently needed to combat severe disease and its complications.
- While adaptive immunity's role in vaccines is understood, the innate immune response to coronaviruses remains largely unexplored.
Purpose of the Study:
- To review the structure of RNA viruses, particularly coronaviruses, and their impact on the lungs and cardiovascular system.
- To examine the role of the pattern recognition protein (PRP) trident in clearing viral particles and apoptotic cells.
- To emphasize pattern recognition protein immune therapies as a potential combination treatment for COVID-19.
Main Methods:
- Review of existing literature on SARS-CoV-2, innate immunity, and pattern recognition proteins.
- Analysis of the composition and function of the PRP trident (Surfactant proteins A/D, MBL, C1q, CRP, IgM).
- Consideration of PRP effects on viral clearance and apoptotic cell removal in pulmonary and cardiovascular systems.
Main Results:
- The PRP trident, comprising specific proteins and antibodies, plays a role in clearing viral particles and apoptotic cells.
- These mechanisms are relevant in both lung tissue and atherosclerotic lesions, suggesting a link between COVID-19 and cardiovascular complications.
- Innate immunity, particularly through PRPs, is critical for managing SARS-CoV-2 infection and preventing severe outcomes.
Conclusions:
- Pattern recognition protein immune therapies offer a promising avenue for combination treatment against SARS-CoV-2.
- Such therapies could prevent severe respiratory distress and reduce pulmonary and cardiovascular complications.
- A comprehensive therapeutic approach integrating all aspects of immunity is essential to overcome the COVID-19 pandemic.
More Related Videos
Related Concept Videos
The Antiviral System of Bacteria and Archaea: CRISPR
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Leaky Scanning
Viral Structure
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
What is the Immune System?

